PAR 3.92% 24.5¢ paradigm biopharmaceuticals limited..

Phase 3 iPPS trial in Australia ?, page-11

  1. 1,316 Posts.
    lightbulb Created with Sketch. 263
    Congrats! Wonderful news. A great start in life with a stake in PAR smile.png
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.